Global Business Innovation Programme in Switzerland - Antimicrobial Resistance (AMR)
Companies developing innovations to combat Antimicrobial Resistance are invited to join a market visit including the 8th AMR Conference in Switzerland.
Note: This opportunity is fully funded support and not monetary funding.
Antimicrobial Resistance (AMR) is one of the major threats to global health. Collaboration is critical to bring new technologies to market which presents many opportunities for businesses to be part of the solution.
We would welcome applications from SMEs who are involved in developing innovations to combat Antimicrobial Resistance in (but not limited to) the following areas:
- Diagnostics,
- Therapeutics
- Stewardship
- Infection control
- Vets
- Vaccines.
-
A GBIP has three stages:
Prepare for the market
Preparing for the market includes the cohort being briefed by sector and market experts on, for example, cultural aspects of conducting business in that country. Delegates receive help to find business partners and arrange meetings and are advised on best practice including the management and protection of their intellectual property.
Visiting the market
Visiting the market provides opportunities to attend pre-arranged meetings and activities in order to better understand and maximise the opportunities that the visit presents.
Exploiting the opportunity
Exploiting the opportunity is arguably the most important aspect of the programme. To maximise the opportunity, participating companies are given bespoke one-to-one support from an Innovate UK EDGE innovation and growth specialist to help develop and implement an action plan.
The Global Business Innovation Programme operates on a competitive basis and businesses selected are required to participate in all three stages (some or all of which may be online).
-
To participate in this GBIP your business must be an SME and established in the UK. An individual senior person from the business will be expected
to participate in all aspects of the GBIP, which include a 2-day workshop 22-23 January and a market visit 3-8 March. -
Switzerland has recognised the importance of AMR, and the Swiss Antibiotic Resistance Strategy (StAR) was created in close cooperation between the Federal Office of Public Health, the Federal Food Safety and Veterinary Office, the Federal Office for Agriculture, the Federal Office for the Environment, and the Swiss Conference of Cantonal Ministers of Public Health. StAR recognises the need to prevent the development of new resistant organisms and limit their transmission and spread and that this is an international issue. The strategy’s implementation which began in early 2016 determined eight strategic fields of activity and objectives and also importantly recognises the cooperation between the different areas is extremely important to ensure each area’s integrity, i.e., a One Health approach. As a consequence, there is a significant AMR Ecosystem within Switzerland.
Currently, the One Health Action Plan 2024-27 of the Strategy Antibiotic Resistance Switzerland (StAR) is being developed with various partners and stakeholders from research, politics, and industry. This is coincidental with the UK developing its next National Plan. Thus, there are clear parallels between the UK and Switzerland.
The 8th AMR Conference will be held in Basel, Switzerland on the 6th and 7th March 2024 focusing on Novel Antimicrobials & AMR Diagnostics. The innovation visit will include access to both days of the conference providing opportunities to hear from world-leading AMR experts, as well as 1-to-1 matchmaking meetings to find new collaborators and partners and to grow your business.
-
- Explore innovation opportunities for AMR collaboration in Switzerland
- Get a better understanding of the challenges and opportunities of doing business in Switzerland
- Find potential innovation collaborators and partners and develop your network in the UK and globally
- Improve your company value proposition to international partners and investors
-
Click here to register for the applicant briefing event on 20 November 2023.
Closing date for application: 12th December 2023
Two-day pre visit workshop: 22nd – 23rd January 2024
Market visit: 3rd – 8th March 2024
For more information, please contact Bita Najafi, Innovation & Growth Specialist, Innovate UK EDGE: enquiries2@innovateukedge.ukri.org or 07729 116379.